Mitsubishi UFJ Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $213K | Buy |
123,598
+91,199
| +281% | +$157K | ﹤0.01% | 972 |
|
2025
Q1 | $108K | Buy |
32,399
+2,715
| +9% | +$9.04K | ﹤0.01% | 1019 |
|
2024
Q4 | $227K | Buy |
29,684
+4,192
| +16% | +$32.1K | ﹤0.01% | 973 |
|
2024
Q3 | $239K | Sell |
25,492
-2,407
| -9% | -$22.6K | ﹤0.01% | 941 |
|
2024
Q2 | $224K | Sell |
27,899
-14,906
| -35% | -$120K | ﹤0.01% | 951 |
|
2024
Q1 | $634K | Sell |
42,805
-1,960
| -4% | -$29K | ﹤0.01% | 846 |
|
2023
Q4 | $354K | Buy |
44,765
+7,277
| +19% | +$57.5K | ﹤0.01% | 954 |
|
2023
Q3 | $171K | Buy |
37,488
+2,060
| +6% | +$9.37K | ﹤0.01% | 1035 |
|
2023
Q2 | $249K | Sell |
35,428
-7,161
| -17% | -$50.4K | ﹤0.01% | 1011 |
|
2023
Q1 | $260K | Buy |
42,589
+2,574
| +6% | +$15.7K | ﹤0.01% | 995 |
|
2022
Q4 | $244K | Buy |
40,015
+23,090
| +136% | +$141K | ﹤0.01% | 1003 |
|
2022
Q3 | $162K | Buy |
16,925
+1,149
| +7% | +$11K | ﹤0.01% | 1049 |
|
2022
Q2 | $174K | Sell |
15,776
-231
| -1% | -$2.55K | ﹤0.01% | 1057 |
|
2022
Q1 | $267K | Buy |
16,007
+909
| +6% | +$15.2K | ﹤0.01% | 1018 |
|
2021
Q4 | $288K | Sell |
15,098
-3,753
| -20% | -$71.6K | ﹤0.01% | 1017 |
|
2021
Q3 | $465K | Hold |
18,851
| – | – | ﹤0.01% | 956 |
|
2021
Q2 | $491K | Buy |
18,851
+8,610
| +84% | +$224K | ﹤0.01% | 957 |
|
2021
Q1 | $324K | Buy |
10,241
+3,633
| +55% | +$115K | ﹤0.01% | 945 |
|
2020
Q4 | $307K | Buy |
6,608
+1,187
| +22% | +$55.1K | ﹤0.01% | 900 |
|
2020
Q3 | $178K | Buy |
5,421
+199
| +4% | +$6.53K | ﹤0.01% | 907 |
|
2020
Q2 | $143K | Sell |
5,222
-2,465
| -32% | -$67.5K | ﹤0.01% | 929 |
|
2020
Q1 | $230K | Buy |
7,687
+1,380
| +22% | +$41.3K | ﹤0.01% | 837 |
|
2019
Q4 | $161K | Sell |
6,307
-2,574
| -29% | -$65.7K | ﹤0.01% | 908 |
|
2019
Q3 | $162K | Buy |
8,881
+1,564
| +21% | +$28.5K | ﹤0.01% | 853 |
|
2019
Q2 | $179K | Sell |
7,317
-8,805
| -55% | -$215K | ﹤0.01% | 842 |
|
2019
Q1 | $153K | Buy |
16,122
+748
| +5% | +$7.1K | ﹤0.01% | 827 |
|
2018
Q4 | $137K | Buy |
15,374
+6,162
| +67% | +$54.9K | ﹤0.01% | 800 |
|
2018
Q3 | $104K | Buy |
+9,212
| New | +$104K | ﹤0.01% | 847 |
|